What disorders does the Connecticut Laboratory Newborn Screening Program screen for?
In 1964, the CT Statewide Laboratory Newborn Screening Program was started with the screening for phenylketonuria (PKU) and galactosemia. Through the years disorders were added to the screening panel. CT has joined other states by implementing the expanded screening using the Tandem Mass Spectrometry Instrument. Currently, Connecticut newborns are screened for 40 disorders. The goal of newborn screening is early identification of infants at increased risk for selected metabolic or genetic disorders, so that medical treatment can be promptly initiated to avert complications and prevent irreversible problems. Over 1.8 million newborns have been tested since the program began. Click the following link for more information about newborn screening.
